Elizabeth McFarland, MD
Pediatric Infectious Diseases
Locations
Practice Locations
Children's Hospital Colorado Anschutz Medical Campus
Aurora
13123 East 16th Ave, Aurora, CO 80045720-777-1234
Provider Expertise
Clinical Interest for Patients
I am interested in pediatric infectious diseases, particularly pediatric and perinatal HIV Infection.
Specialties
- Pediatric Infectious Diseases ( 1992 , 2008 )
- Pediatrics ( 1990 , 2014 )
Conditions & Treatments
-
Kawasaki Disease
-
Immune System
AIDS, AIDS / HIV Disease, AIDS Immunization
-
Symptoms and Manifestations
Fever
-
Infections
Bacterial, Fungal, Influenza, Pneumonia, Viral
Education & Training
Medical Schools
MD, Duke University School of Medicine (1985)
Undergraduate Schools
BS, Northwestern University (IL) (1981)
Internships
University of Colorado (University Hospital) Program (1986)
Residency Program
University of Colorado (University Hospital) Program (1988)
Fellowships
University of Colorado (University Hospital) Program (1992)
Professional Memberships
Pediatric Infectious Disease Society, Member
Research & Grants
Research Interests for Patients
Dr. McFarland’s primary areas of research interest are HIV passive and active immunization and immune-based HIV therapy, the role of HIV-specific cell-mediated immunity in HIV pathogenesis and response to therapy and RSV vaccine clinical trials. She is leading clinical research protocols focused on HIV-1 specific broadly neutralizing monoclonal antibody (bNAb) for infants exposed to HIV-1 and for infant early antiretroviral treatment. She serves as Vice Chair of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) HIV Cure Committee, as member of the Pediatric Advisory Committee to the HIV Vaccine Trials Network (HVTN), as a co-investigator for the Pediatrics Adolescent Virus Eradication (PAVE) Martin Delaney Collaboratory, site principal investigator for the multicenter Pediatric AIDS/HIV Cohort Study (PHACS), and member of the PHACS Nutrition, Metabolic, Growth Working Group. She has served on the AIDS Research Advisory Council, Division of AIDS (DIADS) at the National Institutes of Health (NIH). Dr. McFarland has had continuous NIH and HRSA funding since 1995.
information for referring providers
Referral Contact Phone
(720) 777-6981
Clinical Interests for Referring Providers
I am interested in pediatric infectious diseases, particularly pediatric and perinatal HIV Infection.
Research Interest for Referring Providers
Dr. McFarland’s primary areas of research interest are HIV passive and active immunization and immune-based HIV therapy, the role of HIV-specific cell-mediated immunity in HIV pathogenesis and response to therapy and RSV vaccine clinical trials. She is leading clinical research protocols focused on HIV-1 specific broadly neutralizing monoclonal antibody (bNAb) for infants exposed to HIV-1 and for infant early antiretroviral treatment. She serves as Vice Chair of the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) HIV Cure Committee, as member of the Pediatric Advisory Committee to the HIV Vaccine Trials Network (HVTN), as a co-investigator for the Pediatrics Adolescent Virus Eradication (PAVE) Martin Delaney Collaboratory, site principal investigator for the multicenter Pediatric AIDS/HIV Cohort Study (PHACS), and member of the PHACS Nutrition, Metabolic, Growth Working Group. She has served on the AIDS Research Advisory Council, Division of AIDS (DIADS) at the National Institutes of Health (NIH). Dr. McFarland has had continuous NIH and HRSA funding since 1995.